| Literature DB >> 20339692 |
Rogério Aparecido Dedivitis1, Elio Gilberto Pfuetzenreiter, Carlos Eduardo Molinari Nardi, Emmanuel Casotti Duque de Barbara.
Abstract
UNLABELLED: Hypocalcemia can be detected clinically and through lab tests after thyroidectomy. AIM: To analyze the incidence and risk factors of clinical and laboratorial hypocalcemia after thyroid surgery.Entities:
Mesh:
Year: 2010 PMID: 20339692 PMCID: PMC9446011
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Patient distribution according to demographic variables.
| Variable | Categories / Measurements | Freq (%) / Measurements |
|---|---|---|
| Gender | Male | 7 (7,7) |
| Female | 84 (92,3) | |
| Age (years) | N | 91 |
| Minimum-maximum | 18–82 | |
| Median | 50 | |
| Mean | 49,3 | |
| Standard deviation | 14,0 | |
| Clinical Diagnosis | NTUG | 39 (42,9) |
| NTMG | 40 (44,0) | |
| Cancer | 12 (13,2) | |
| Procedure | Partial | 45 (49,4) |
| TT | 44 (48,4) | |
| TT + NC | 2 (2,2) | |
| Weight | N | 91 |
| Minimum-maximum | 6–320 | |
| Median | 25 | |
| Mean | 36,6 | |
| Standard deviation | 40,3 | |
| Pathology tests | Goiter | 51 (56,0) |
| Adenoma | 19 (20,9) | |
| Cancer | 21 (23,1) | |
| Thyroiditis | No | 46 (50,6) |
| Yes | 45 (49,4) | |
| Clinical HPT | No | 80 (87,9) |
| Yes | 11 (12,1) | |
| Laboratorial HPT at 48h | No | 69 (75,8) |
| Yes | 22 (24,2) | |
| Laboratorial HPT at 1 month | No | 85 (93,4) |
| Yes | 6 (6,6) | |
TT = total thyroidectomy; NC = neck clearance; HPT = hypoparathyroidism
Patient distribution according to clinical hypoparathyroidism.
| Variable | Categories | Clinical HPT | p-value | |
|---|---|---|---|---|
| NO N(%) | YES N(%) | |||
| Gender | Male | 7 (100,0) | 0 (0,0) | 0,592 |
| Female | 73 (86,9) | 11 (13,1) | ||
| Age range (years) | < 50 | 44 (95,6) | 2 (4,4) | 0,022* |
| > 50 | 36 (80,0) | 9 (20,0) | ||
| Clinical diagnosis | NTUG | 38 (97,4) | 1 (2,6) | N/A |
| NTMG | 32 (80,0) | 8 (20,0) | ||
| Cancer | 10 (83,3) | 2 (16,7) | ||
| Diagnosed with Multinodular Goiter | Non-NTMG | 48 (94,1) | 3 (5,9) | 0,054 |
| NTMG | 32 (80,0) | 8 (20,0) | ||
| Procedure | Partial | 45 (100,0) | 0 (0,0) | N/A |
| TT | 33 (75,0) | 11 (20,0) | ||
| TT + NC | 2 (100,0) | 0 (0,0) | ||
| Partial procedure | Partial | 45 (100,0) | 0 (0,0) | < 0,001* |
| Non-partial | 35 (76,1) | 11 (23,9) | ||
| Weight | < 25 | 43 (89,6) | 5 (10,4) | 0,605* |
| > 25 | 37 (86,0) | 6 (14,0) | ||
| Pathology tests | Goiter | 44 (86,3) | 7 (13,7) | N/A |
| Adenoma | 18 (94,7) | 1 (5,3) | ||
| Cancer | 18 (85,7) | 3 (14,3) | ||
| Thyroiditis | No | 42 (91,3) | 4 (8,7) | 0,316 |
| Yes | 38 (84,4) | 7 (15,6) | ||
p-value obtained through Fisher's exact test; * p-value obtained through chi-square test; N/A = not applicable; NTUG = nontoxic uninodular goiter; NTMG = nontoxic multinodular goiter; TT = total thyroidectomy; NC = neck clearance.
Patient distribution according to laboratorial hypoparathyroidism at 48 hours.
| Variable | Categories | Laboratorial HPT at 48h | p-value | |
|---|---|---|---|---|
| NO N(%) | YES N(%) | |||
| Gender | Male | 7 (100,0) | 0 (0,0) | 0,189 |
| Female | 62 (73,8) | 22 (26,2) | ||
| Age range (years) | < 50 | 38 (82,6) | 8 (17,4) | 0,126* |
| > 50 | 31 (68,9) | 14 (31,1) | ||
| Clinical diagnosis | NTUG | 33 (84,6) | 6 (15,4) | N/A |
| NTMG | 27 (67,5) | 13 (32,5) | ||
| Cancer | 9 (75,0) | 3 (25,0) | ||
| Diagnosed with NTMG | Non-NTMG | 42 (82,4) | 9 (17,6) | 0,100 |
| NTMG | 27 (67,5) | 13 (32,5) | ||
| Procedure | Partial | 40 (88,9) | 5 (11,1) | N/A |
| TT | 27 (61,4) | 17 (38,6) | ||
| TT+NC | 2 (100,0) | 0 (0,0) | ||
| Partial Procedure | Partial | 40 (88,9) | 5 (11,1) | 0,004* |
| Non-partial | 29 (63,0) | 17 (37,0) | ||
| Weight | < 25 | 38 (79,2) | 10 (20,8) | 0,431* |
| > 25 | 31 (72,1) | 12 (27,9) | ||
| Pathology tests | Goiter | 37 (72,6) | 14 (27,4) | N/A |
| Adenoma | 16 (84,2) | (15,8) | ||
| Cancer | 16 (76,2) | 5 (23,8) | ||
| Thyroiditis | No | 38 (82,6) | 8 (17,4) | 0,126 |
| Yes | 31 (68,9) | 14 (31,1) | ||
p-value obtained through Fisher's exact test; * p-value obtained through chi-square test; N/A = not applicable; NTUG = nontoxic uninodular goiter; NTMG = nontoxic multinodular goiter; TT = total thyroidectomy; NC = neck clearance.
Distribution according to laboratorial hypoparathyroidism at one month.
| Variable | Categories | Laboratorial HPT at 1 month | p-value | |
|---|---|---|---|---|
| NO N(%) | YES N(%) | |||
| Gender | Male | 7 (100,0) | 0 (0,0) | > 0,999 |
| Female | 78 (92,9) | 6 (7,1) | ||
| Age range (years) | < 50 | 42 (91,3) | 4 (8,7) | 0,677 |
| > 50 | 43 (95,6) | 2 (4,4) | ||
| Clinical diagnosis | NTUG | 38 (97,4) | 1 (2,6) | N/A |
| NTMG | 36 (90,0) | 4 (10,0) | ||
| Cancer | 11 (91,7) | 1 (8,3) | ||
| Diagnosed with NTMG | Non-NTMG | 49 (96,1) 3 | 2 (3,9) | 0,399 |
| NTMG | 6 (90,0) | 4 (10,0) | ||
| Procedure | Partial | 44 (97,8) | 1 (2,2) | N/A |
| TT | 39 (88,6) | 5 (11,4) | ||
| TT+NC | 2 (100,0) | 0 (0,0) | ||
| Partial Procedure | Partial | 44 (97,8) | 1 (2,2) | 0,203 |
| Non-partial | 41 (89,1) | 5 (10,9) | ||
| Weight | < 25 | 45 (93,8) | 3 (6,2) | > 0,999 |
| > 25 | 40 (93,0) | 3 (7,0) | ||
| Pathology tests | Goiter | 48 (94,1) | 3 (5,9) | N/A |
| Adenoma | 17 (89,5) | 2 (10,5) | ||
| Cancer | 20 (95,2) | 1 (4,8) | ||
| Thyroiditis | No | 43 (93,5) | 3 (6,5) | > 0,999 |
| Yes | 42 (93,3) | 3 (6,7) | ||
p-value obtained through Fisher's exact test; N/A = not applicable; NTUG = nontoxic uninodular goiter; NTMG = nontoxic multinodular goiter; TT = total thyroidectomy; NC = neck clearance.
Distribution according to laboratorial hypoparathyroidism at 48 hours and one month.
| Variable | Categories | Laboratorial HPT at 1 month | p-value | |
|---|---|---|---|---|
| NO N(%) | YES N(%) | |||
| Laboratorial HPT at 48 | No | 69 (100,0) | 0 (0,0) | < 0,001 |
| Yes | 16 (72,7) | 6 (27,3) | ||
p-value obtained from McNemar's test